医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NuGEN Technologies Launches “Sharing Experiences and Applications in Science” (SEAS) Institute

2016年03月08日 AM12:00
このエントリーをはてなブックマークに追加


 

SAN CARLOS, Calif.

NuGEN Technologies, Inc. today announced the launch of the “Sharing Experiences and Applications in Sciences” (SEAS) Institute, the company’s platform for supporting and spotlighting the work of innovative scientists.

“This industry-first program provides an active environment for scientists to communicate, connect, and drive their research forward,” said Elizabeth Hutt, CEO of NuGEN. “As the leading provider of transformative technology addressing challenging sample types, we are ideally positioned to support scientists working on understanding disease to help change lives.”

The SEAS Institute enables scientists to share application-focused research studies and knowledge via industry conferences, webinars and white papers. Individuals that choose to participate (referred to as “SEAS Leaders”) can connect with their peers and gain visibility within the scientific community for their new approaches and advances. SEAS Leaders can choose from Bronze, Silver, and Gold levels of participation with each level offering benefits/remuneration to match their level of participation. In addition, SEAS Leaders can benefit from the increased awareness of their work to potentially secure grant money.

To find out more about becoming a SEAS Leader and the associated benefits, contact NuGEN at: SEAS@nugen.com

About NuGEN Technologies, Inc.

NuGEN Technologies, Inc. is a rapidly-growing, privately-held company that provides innovative products and systems used to prepare biologic samples for targeted genomic analysis. Founded in 2000 and based in San Carlos, CA, NuGEN has long been at the cutting edge of genomic technology, with accurate, cost-effective reagent kits for even the most challenging sample types. NuGEN products are used in more than 1000 leading life science institutes and in diagnostic and pharmaceutical companies in 40 countries. To learn more about NuGEN visit www.nugen.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160307005366/en/

CONTACT

NuGEN Technologies, Inc.
Carol Short, 650-590-3002
media@nugen.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Takeda’s Dengue Vaccine Candidate Elicited Broad Immune Responses in Children and Adolescents Living in Dengue-Endemic Areas; Interim Phase 2 Analysis Published in The Lancet Infectious Diseases
  • Heliae宣布首次使用TruAzta品牌的天然虾青素
  • ノボキュア社が日本で第2世代オプチューンの薬事承認を厚生労働省から取得
  • Heliae Announces First Use of Branded TruAzta Natural Astaxanthin
  • Visioneering Technologies, Inc. Successfully Lists on ASX